FLI1 and prostate carcinoma: The SLFN11 promoter contains several ETS binding sites and functions as an ETS factor response gene, with ETS transcription factors FLI1 and ETS1 having proposed roles in regulating SLFN11 expression in colon, breast, and prostate cancers [25].